The groups were well-matched for sex, age, and follow-up duration
Rushad Patell, analyzed the data of more than 558,000 patients in the United States.They compared people who used GLP-1 medications with those who took an older medication, called DPP4I.The results were encouraging: People who took LPG-1 had 20% less risk of developing TEV compared to those used by DPP4I
This approach helps support energy production, detoxification pathways, and neurological function in a coordinated way
Es asimismo muy interesante la capacidad de GLP-1 para inducir distintos efectos, denominados extrapancreticos o extraglucmicos, entre los que se encuentra el retraso en el vaciamiento gstrico, la supresin del apetito y, en modelos in vitro, la inhibicin de la apoptosis de las clulas beta pancrticas y la presencia de efectos de proteccin cardiovascular
Why users love it: Extensive food library and simple logging make it easy to track nutrition consistently
Kidd, P